Barclays’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Barclays’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-72,400	Closed	-$2.99M	–	5332
2022 Q1	$2.99M	Buy	+72,400	New	+$2.55M	﹤0.01%	1561

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's SILK Position: Q3 2024 in Review

Barclays sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 14,569 shares — an estimated $394K sold.

Barclays first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $2.59M in Q4 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Barclays reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Barclays sold 14,569 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $394K.
Barclays first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
Barclays's Silk Road Medical, Inc. Common Stock position peaked at $2.59M in Q4 2020.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.